Define antimicrobial resistance (AMR) and explain how animal, human, and environmental use contribute.

Study for the One Health Practice Exam. Our interactive quiz includes multiple-choice questions with detailed explanations to enhance your understanding. Prepare effectively for your exam today!

Multiple Choice

Define antimicrobial resistance (AMR) and explain how animal, human, and environmental use contribute.

Explanation:
Antimicrobial resistance happens when microbes acquire the ability to survive exposure to medicines designed to kill or inhibit them. This resistance grows under selective pressure from antimicrobial use: when antibiotics are used in people, animals, or released into the environment, susceptible microbes are reduced while resistant ones survive and multiply, and resistance traits can spread to other microbes through reproduction or gene transfer. Over time, resistant strains become more common and can move between humans, animals, and the environment. Human use contributes through patterns like overuse, inappropriate prescribing, and not completing courses, which select for resistant organisms in people and their microbiomes. In animals, antibiotics are used for treatment, prevention, and growth promotion; resistant bacteria shed from animals can contaminate meat, water, and soil, reaching people and other animals. In the environment, antibiotic residues and resistant bacteria enter water and soil from farms, clinics, and manufacturing, creating reservoirs of resistance genes that can be transferred among diverse microbes and ultimately reach human and animal pathogens. Because these pathways connect across sectors, AMR is a One Health issue requiring coordinated actions in medicine, veterinary care, and environmental management. Vaccine resistance is a different concept, so vaccines becoming ineffective is not AMR. AMR is about microbes resisting drugs, not about vaccine effectiveness, and it involves drug resistance rather than mere pathogen spread or host immune adaptation.

Antimicrobial resistance happens when microbes acquire the ability to survive exposure to medicines designed to kill or inhibit them. This resistance grows under selective pressure from antimicrobial use: when antibiotics are used in people, animals, or released into the environment, susceptible microbes are reduced while resistant ones survive and multiply, and resistance traits can spread to other microbes through reproduction or gene transfer. Over time, resistant strains become more common and can move between humans, animals, and the environment.

Human use contributes through patterns like overuse, inappropriate prescribing, and not completing courses, which select for resistant organisms in people and their microbiomes. In animals, antibiotics are used for treatment, prevention, and growth promotion; resistant bacteria shed from animals can contaminate meat, water, and soil, reaching people and other animals. In the environment, antibiotic residues and resistant bacteria enter water and soil from farms, clinics, and manufacturing, creating reservoirs of resistance genes that can be transferred among diverse microbes and ultimately reach human and animal pathogens.

Because these pathways connect across sectors, AMR is a One Health issue requiring coordinated actions in medicine, veterinary care, and environmental management.

Vaccine resistance is a different concept, so vaccines becoming ineffective is not AMR. AMR is about microbes resisting drugs, not about vaccine effectiveness, and it involves drug resistance rather than mere pathogen spread or host immune adaptation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy